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). 138
To test whether CHIR090 or cerulenin had any effect on the interaction of colistin or polymyxin B with LPS in 139 the OM of P. aeruginosa cells, we used the N-phenyl-1-napthylamine (NPN) fluorophore to measure OM 140 permeablisation caused by the polymyxin antibiotics [27] . This revealed that both colistin and polymyxin B 141 caused immediate and equal disruption of the OM of untreated bacteria and those exposed to CHIR090 or 142 cerulenin, confirming that the LPS biosynthesis inhibitors did not modulate the levels of LPS in the OM (Fig.  143 1ef, Supplementary Fig. 5 ). 144
Having established that depletion of LPS from the CM using CHIR090 or cerulenin had no effect on the 145 interaction of colistin or polymyxin B with the OM, we turned our attention to the interaction of the 146 polymyxin antibiotics with the CM. To do this, we measured the binding of BoDipy-labelled colistin or BoDipy-147 polymyxin B to P. aeruginosa cells exposed, or not, to CHIR090 or cerulenin ( Supplementary Fig. 6, 7) . In the 148 absence of the inhibitors of LPS biosynthesis, there was a rapid and high level of binding of the labelled 149 polymyxin antibiotics to bacteria (Fig. 1gh ). By contrast, when LPS was depleted from the CM using CHIR090 150 or cerulenin, the binding of BoDipy-colistin or BoDipy-polymyxin B was significantly reduced, indicating that 151 LPS in the CM was targeted by the polymyxin antibiotics ( Fig. 1gh) . 
160
Representative fluorescence microscopy images visualising LPS in the OM of P. aeruginosa PA14 whole cells (a) or in the 161 CM of spheroplasts of P. aeruginosa (b) in the absence of treatment, or after exposure to the LPS biosynthesis inhibitors 162 CHIR090 (0.125 μg ml -1 ) or cerulenin (32 μg ml -1 ) for 2 hours, using 7 μg ml -1 BoDipy-polymyxin B nonapeptide (PMBN) 163 (Scale bars: 5 µm). c, d, Quantification of amount of LPS in the OM of P. aeruginosa PA14 whole cells (c) or in the CM of 164 P. aeruginosa spheroplasts (d) exposed, or not, to CHIR090 (0.125 μg ml -1 ) or cerulenin (32 μg ml -1 ) for 2 hours, as 165 determined by fluorescence of BoDipy-PMBN (7 μg ml -1 ) bound to the cell surface (n=3 in triplicate; ns: p>0.05, *p<0.001 166 7 compared to Untreated conditions). e, f, OM disruption of P. aeruginosa PA14 cells during 10 minutes of exposure to 167 colistin (4 μg ml -1 ) (e) or polymyxin B (PMB, 4 μg ml -1 ) (f), in the absence or presence of CHIR090 (0.125 μg ml -1 ) or 168 cerulenin (32 μg ml -1 ), as assessed by uptake of the fluorescent dye NPN (10 µM) (n=3, each data point represents the 169 arithmetic mean of 20 replicate measurements; no significant differences (p>0.05) between polymyxin treated 170 bacteria). g, h, Binding of fluorescent BoDipy-labelled colistin (5 μg ml -1 ) (g) or BoDipy-PMB (10 μg ml -1 ) (h) to P. 171 aeruginosa PA14 cells in the absence or presence of CHIR090 (0.125 μg ml -1 ) or cerulenin (32 μg ml -1 ) (n=4; *p<0.0001 Having demonstrated that colistin and polymyxin B target LPS in the CM, we wanted to understand whether 180 this interaction was needed for the bactericidal activity of the antibiotics. To do this, we depleted LPS from 181 the CM of P. aeruginosa using CHIR090 or cerulenin and measured bacterial survival over time during 182 exposure to the polymyxins. As expected, colistin alone caused a rapid and substantial drop in c.f.u. counts 183 of bacteria in the absence of inhibitors of LPS biosynthesis, with >10,000-fold reduction in survival within 4 184 hours ( Fig. 2ab ). By contrast, there was almost no decrease in c.f.u. counts over 8 hours when P. aeruginosa 185 was exposed to colistin in the presence of CHIR090 or cerulenin to deplete LPS from the CM (Fig. 2ab ). This 186 effect was dose-dependent, with the protection conferred by CHIR090 and cerulenin against colistin-187 mediated killing reduced as the concentration of the LPS biosynthesis inhibitors was decreased 188 ( Supplementary Fig. 8 ). Removing LPS from the CM with CHIR090 or cerulenin also prevented polymyxin B 189 from exerting its bactericidal effects, with >1000-fold increased survival of P. aeruginosa in the presence of 190 the inhibitors of LPS biosynthesis compared to bacteria exposed to polymyxin B alone ( Fig. 2c ). Furthermore, 191 the protective effects of CHIR090 and cerulenin could also be observed even after bacteria were first exposed 192 to colistin. After 2 hours incubation with colistin, c.f.u. counts of P. aeruginosa dropped approximately 500-193 fold compared to the starting inoculum ( Fig. 2d ). In the absence of CHIR090 or cerulenin, killing continued 194 with an additional 1000-fold decrease in survival over the next 4 hours ( Fig. 2d ). However, the addition of 195 cerulenin after 2 hours completely halted bacterial killing, whilst the introduction of CHIR090 reduced the 196 rate of killing significantly ( Fig. 2d ). Therefore, depletion of LPS from the CM significantly inhibited the 197 bactericidal activity of colistin against P. aeruginosa, even after the antibiotic had bound to cells. 198
Since perturbation of LPS biosynthesis by CHIR090 or cerulenin may have triggered stress responses 199 activating the PmrAB or PhoPQ two-component systems that modulate the susceptibility of P. aeruginosa to 200 colistin, we repeated the killing experiments using transposon mutants with disrupted copies of pmrA, pmrB, 201 8 phoP or phoQ [28, 29] . As expected from previous work, the phoQ-disrupted mutant was less susceptible to 202 colistin than the WT strain ( Supplementary Fig. 9 ) [30] . However, the presence of CHIR090 or cerulenin 203 significantly reduced the killing of all four mutants by colistin, indicating that depletion of LPS from the CM, 204 rather than the induction of stress responses and modification of LPS in the OM, was responsible for the 205 protection conferred by the LPS biosynthesis inhibitors against colistin ( Supplementary Fig. 9 ). Moreover, 206 neither CHIR090 nor cerulenin had any effect on the ability of the bactericidal agents ciprofloxacin, 207 gentamicin, imipenem or ethylenediaminetetraacetic acid (EDTA) to kill P. aeruginosa, further confirming 208 that the effects of blocking LPS biosynthesis were specific to polymyxins, and not a consequence of general 209 stress responses reducing antibiotic susceptibility ( Supplementary Fig. 10 ). 210
Since growth rate can affect the bactericidal activity of antibiotics, it was possible that the protection 211 provided by CHIR090 or cerulenin against colistin-mediated killing was due to their slight inhibitory effects 212 on cell replication ( Supplementary Fig. 4 ) [31, 32] . However, a range of completely growth-inhibitory 213 concentrations of the bacteriostatic antibiotics tetracycline or chloramphenicol had almost no effect on 214 colistin-mediated killing, confirming that alterations in growth rate due to the presence of CHIR090 or 215 cerulenin were not the basis of their protective effects against polymyxins ( Supplementary Fig. 11 ). 216
Additionally, we confirmed using checkerboard broth microdilution assays that neither LPS biosynthesis 217 inhibitor displayed synergy with colistin, suggesting that CHIR090 and cerulenin did not have enhanced 218 growth-inhibitory effects in combination with the polymyxin antibiotic ( Supplementary Fig. 12 ). This also 219 revealed that the inhibitors of LPS biosynthesis did not directly interfere with colistin, for example by binding 220 to the polymyxin ( Supplementary Fig. 12 ). 221 After isolating P. aeruginosa mutants that were resistant to CHIR090, we found that the LPS biosynthesis 222 inhibitor did not prevent colistin-mediated killing of these CHIR090-resistant strains, demonstrating that the 223 inhibitor was not blocking the bactericidal effects of the polymyxin antibiotic via off-target effects 224 ( Supplementary Fig. 13 ). Furthermore, we tested whether either CHIR090 or cerulenin triggered P. 225 aeruginosa to release outer membrane vesicles (OMVs) that could inactivate colistin extracellularly by 226 measuring the concentration of membrane phospholipids and LPS in the culture supernatant [33] . Exposure 227 of bacteria to the LPS biosynthesis inhibitors in combination with colistin resulted in a decrease in the amount 228 of these key OMV components shed from the cell surface, with higher levels of colistin activity maintained in 229 the supernatant in the presence of CHIR090 or cerulenin ( Supplementary Fig. 14, 15 ). From these 230 experiments, we concluded that the protection conferred by the inhibitors of LPS biosynthesis against killing 231 of P. aeruginosa by polymyxins was specifically due to their effects on depleting LPS from the CM. 232
To determine whether the protective effects of CHIR090 or cerulenin also applied to other Gram-negative 233 pathogens, we exposed clinical isolates of E. coli and K. pneumoniae, as well as P. aeruginosa, to colistin in 234 the absence or presence of sub-lethal concentrations of the LPS biosynthesis inhibitors. As observed for P. 235 aeruginosa PA14, there was a large and rapid drop in c.f.u. counts of all strains exposed to colistin alone, but 236 9 the introduction of either CHIR090 or cerulenin significantly reduced the rate and magnitude of killing, 237 suggesting the polymyxin antibiotic had a broadly conserved mechanism against Gram-negative bacteria 238 ( Supplementary Fig. 16 ). Next, we used scanning electron microscopy (SEM) to examine the morphology of 239 P. aeruginosa cells exposed to colistin alongside either CHIR090 or cerulenin. As expected, in the absence of 240 antibiotics, bacteria had a typical rod-like appearance, whilst cells exposed to colistin had a greatly altered 241 morphology, with a distorted and deflated appearance ( Fig. 2ef ). However, cells exposed to colistin in the 242 presence of CHIR090 or cerulenin had an almost normal appearance, underlining the protective effects of 243 LPS depletion from the CM ( Fig. 2gh , Supplementary Fig. 17 ). 244
In summary, these findings revealed that the bactericidal activity of polymyxin antibiotics was dependent 245 upon the presence of LPS in the CM of clinically-important pathogens. 248 aeruginosa PA14 cells exposed to colistin (4 μg ml -1 ), the LPS biosynthesis inhibitor CHIR090 (0.125 μg ml -1 ), both 249 antibiotics, or neither (n=4; *p<0.01 compared to Colistin alone). Values for CHIR090 alone and Untreated overlap. b, 250 Survival of P. aeruginosa PA14 cells during exposure to colistin (4 μg ml -1 ), the LPS biosynthesis inhibitor cerulenin (32 251 μg ml -1 ), both antibiotics, or neither (n=4; *p<0.0001 compared to Colistin alone). c, Survival of P. aeruginosa PA14 cells 252 during exposure to polymyxin B (PMB, 4 μg ml -1 ) alone, or in combination with CHIR090 (0.125 μg ml -1 ) or cerulenin (32 253 μg ml -1 ) (n=4; *p<0.05 compared to PMB alone). d, Survival of P. aeruginosa PA14 cells exposed to colistin (4 μg ml -1 ) 254 alone for 2 hours, followed by no further treatment, or the addition of either CHIR090 (0.125 μg ml -1 ) or cerulenin (32 255 μg ml -1 ) (n=3; *p<0.05 compared to Colistin alone). e-h, Representative scanning electron microscopy (SEM) images of 256 P. aeruginosa PA14 cells incubated in broth only (e), broth containing colistin (4 μg ml -1 ) alone (f), colistin (4 μg ml -1 ) and 257 CHIR090 (0.125 μg ml -1 ) (g), or colistin (4 μg ml -1 ) and cerulenin (32 μg ml -1 ) (h), for 2 hours in each case (Scale bars: 200 258 nm). Data in a-d were analysed by a two-way ANOVA with Sidak's (a, b), Dunnett's (c) or Holm-Sidak's (d) post-hoc tests.
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Data are presented as the arithmetic mean, and error bars represent the standard deviation of the mean.
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Colistin-mediated lysis is dependent on the presence of LPS in the cytoplasmic membrane 261
Having established that the bactericidal activity of colistin required the presence of LPS in the CM, we wanted 262 to determine whether this was due to colistin-mediated CM damage being dependent on interactions with 263 LPS in the CM. To do this, we first examined how variations in the amount of LPS in the CM of whole P. 264 aeruginosa cells affected permeabilisation of the CM by polymyxin antibiotics. As expected, exposure of 265 bacteria to colistin or polymyxin B alone caused disruption of the CM, resulting in a significant signal from 266 the DNA-reactive fluorophore propidium iodide (PI) ( Fig. 3ab, Supplementary Fig. 18 ) [34] . By contrast, cells 267 exposed to colistin when LPS was depleted from the CM with the LPS biosynthesis inhibitors CHIR090 or 268 cerulenin had an almost absent PI signal, indicating that the CM remained intact (Fig. 3ab ). Similar results 269 were seen with clinical isolates of P. aeruginosa, K. pneumoniae and E. coli, with CHIR090 significantly 270 reducing colistin-mediated permeabilisation of the CM ( Supplementary Fig. 19 ). 271
To confirm that these data arose from the lack of LPS in the CM, we produced spheroplasts enclosed by only 272 a CM from P. aeruginosa cells that had been exposed, or not, to CHIR090 or cerulenin. In the absence of any 273 antibiotics, there was a gradual loss of integrity of the spheroplast CM, as determined by the signal from PI 274 staining ( Fig. 3c ). By contrast, challenging the spheroplasts with colistin resulted in a high level of 275 fluorescence, indicative of severe CM permeabilisation ( Fig. 3c ). However, when spheroplasts from bacteria 276 pre-treated with CHIR090 or cerulenin to deplete LPS from the CM were exposed to colistin, the signal from 277 PI was similar to that seen in the absence of the polymyxin antibiotic ( Fig. 3c ). Therefore, the ability of colistin 278 to disrupt the CM of P. aeruginosa was dependent upon the presence of LPS in the CM. 279
To test whether this requirement of LPS in the CM for polymyxin-mediated CM disruption was also associated 280 with bacterial lysis, we measured the optical density (OD595nm) of bacterial suspensions exposed to colistin or 281 polymyxin B in the absence or presence of the LPS biosynthesis inhibitors CHIR090 or cerulenin. Whilst 282 colistin alone caused lysis of P. aeruginosa, with a steady decrease in OD595nm readings observed, this was 283 completely blocked in the presence of CHIR090 or cerulenin ( Fig. 3d ). Almost identical data were produced 284 when bacteria were challenged with polymyxin B, or with P. aeruginosa spheroplasts exposed to colistin ( Fig.  285 3ef). In all cases, when the CM was depleted of LPS using the inhibitors of LPS biosynthesis, there was no 286 detectable cell lysis triggered by the polymyxin antibiotics ( Fig. 3def ). This finding was then extended to 287 clinical isolates of Gram-negative pathogens, with CHIR090 significantly reducing colistin-mediated lysis in P. 288 aeruginosa, E. coli and K. pneumoniae strains ( Supplementary Fig. 20) . 289
Taken together, these data demonstrate that polymyxins were dependent on the presence of LPS in the CM 290 in order to permeabilise the CM and cause bacterial lysis. 
295
Disruption of the CM of P. aeruginosa PA14 cells during incubation with colistin (4 μg ml -1 ) in the absence or presence 296 of CHIR090 (0.125 μg ml -1 ) or cerulenin (32 μg ml -1 ), or with a bactericidal concentration of ciprofloxacin (4 μg ml -1 ) as a 297 negative control, as determined using 2.5 µM propidium iodide (PI) (n=3 in duplicate; *p<0.0001 compared to Colistin 298 alone for all populations below the asterisks). b, CM disruption of P. aeruginosa PA14 cells exposed to polymyxin B 299 (PMB, 4 μg ml -1 ) in the absence or presence of CHIR090 (0.125 μg ml -1 ) or cerulenin (32 μg ml -1 ), as determined using 300 2.5 µM PI (n=4; *p<0.0001 compared to PMB alone). c, Permeabilisation of the CM of P. aeruginosa PA14 spheroplasts 301 by colistin (4 μg ml -1 ) following exposure, or not, of bacteria to CHIR090 (0.125 μg ml -1 ) or cerulenin (32 μg ml -1 ) for 2 302 hours prior to conversion to spheroplasts, as determined using 0.25 µM PI (n=3, experiment performed on 3 303 independent occasions; *p<0.05 for CHIR090 and cerulenin pre-treated spheroplasts compared to spheroplasts exposed 304 only to colistin). d, e, Lysis of P. aeruginosa PA14 cells during exposure to colistin (4 μg ml -1 ) (d) or PMB (4 μg ml -1 ) (e) 305 in the absence or presence of CHIR090 (0.125 μg ml -1 ) or cerulenin (32 μg ml -1 ), as measured using OD595nm readings 306 (n=4; *p<0.05 compared to Colistin/PMB alone). f, Lysis of P. aeruginosa PA14 spheroplasts in response to colistin (4 μg 307 ml -1 ) following exposure, or not, of bacteria to CHIR090 (0.125 μg ml -1 ) or cerulenin (32 μg ml -1 ) for 2 hours prior to 308 conversion to spheroplasts, measured by OD600nm readings (n=3, experiment performed on 3 independent occasions; 309 *p<0.05 for CHIR090 and cerulenin pre-treated spheroplasts compared to spheroplasts exposed only to colistin, error 
MCR-1 confers colistin resistance via modified LPS in the cytoplasmic membrane 315
Colistin resistance is a growing concern, particularly the plasmid-borne mobilized colistin resistance (mcr) 316 family of resistance determinants that add a phosphoethanolamine group to the lipid A domain of LPS 317 [10, 11] . It has been proposed that the increased positive charge of LPS molecules conferred by the cationic 318 phosphoethanolamine moiety leads to electrostatic repulsion of colistin away from the surface of bacteria 319 [10, 11] . However, previous work has shown that colistin permeabilises the OM of bacteria expressing mcr-1 320 almost as efficiently as strains that do not express mcr-1 [17] . Notably, it has also been demonstrated that 321 MCR-1 is present in the CM, suggesting this is where modifications to LPS occur, before the molecules are 322 transported to the OM [11, 35] . Therefore, having established that colistin kills Gram-negative pathogens by 323 targeting LPS in the CM, we hypothesised that MCR-1, which prevents polymyxin-mediated bacterial lysis, 324 confers colistin resistance due to the presence of modified LPS in the CM rather than the OM [17] . 325
To investigate this hypothesis, we used an E. coli strain, the most common host organism for these resistance 326 genes, expressing mcr-1 from a plasmid [36] . As expected, E. coli expressing mcr-1 had a significantly greater 327 colistin minimum inhibitory concentration (MIC, 2 µg ml -1 ) compared to an otherwise isogenic empty plasmid 328 control strain that did not express the resistance determinant (0.25 µg ml -1 ) ( Supplementary Fig. 21 ). This 329 confirmed that MCR-1 was being produced by the E. coli cells and that it was functional, whilst expression of 330 mcr-1 did not result in a significant growth defect ( Supplementary Fig. 21) . 331
Next, we verified previous findings by showing that colistin, across a range of antibiotic concentrations, 332 caused similar levels of OM disruption in the E. coli strain expressing mcr-1 and in E. coli cells harbouring only 333 an empty plasmid (Fig. 4a) [17]. Thus, it appeared that MCR-1 did not mediate colistin resistance at the level 334 of the OM. By contrast, whilst colistin compromised the CM of control empty plasmid-containing E. coli, it 335 had no effect on the CM of bacteria expressing mcr-1, as determined by the entry of PI into the cytoplasm 336 ( Fig. 4b ). This suggested that MCR-1 protected bacteria from colistin-mediated permeabilisation of the CM, 337 not the OM. In keeping with this, colistin induced lysis of E. coli with only the empty plasmid, but cells 338 expressing mcr-1 with an intact CM grew in the presence of the antibiotic (Fig. 4c) . 339
To further test whether MCR-1 protected bacteria from colistin by modifying LPS in the CM, we examined 340 the activity of the polymyxin antibiotic against spheroplasts generated from E. coli whole cells either 341 expressing mcr-1 or harbouring an empty plasmid ( Supplementary Fig. 22 ). Colistin caused significant CM 342 damage and triggered cell lysis in empty plasmid-containing E. coli spheroplasts (Fig. 4de ). However, against 343 spheroplasts of the E. coli strain producing MCR-1, the ability of colistin to disrupt the CM was minimal, and 344 there was no observable lysis in response to the polymyxin (Fig. 4de ). Therefore, we concluded that MCR-1 Colistin is an increasingly important last-resort antibiotic used to combat infections caused by multi-drug-370 resistant Gram-negative pathogens, including P. aeruginosa, K. pneumoniae and E. coli [1] [2] [3] . However, 371 treatment failure occurs frequently, and resistance is a growing concern [5-9]. Efforts to address these issues 372 are compromised by a poor understanding of colistin's bactericidal mode of action. Whilst the initial 373 interactions of colistin with LPS in the OM of Gram-negative bacteria were well-established, it was unclear 374 how the antibiotic traversed the OM and damaged the CM to cause cell lysis ( Supplementary Fig. 1 ). In this 375 work, we demonstrate that colistin targets LPS in the CM prior to transport to the OM, resulting in membrane 376 permeabilization, bacterial lysis and killing (Fig. 5) . 
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It has previously been hypothesised that polymyxins damage the phospholipid bilayer in the CM via a 388 detergent-like effect due to the surfactant properties of the antibiotic lipid tail [1, 2] . However, our data 389
showing that colistin requires LPS to be present in the CM in order to kill bacteria explains how an antibiotic 390 with high affinity and specificity for LPS causes disruption to both the OM and CM. Furthermore, these 391 findings provide support for the observations that colistin does not damage the OM of resistant A. baumannii 392 isolates where LPS has been replaced by a phospholipid bilayer, and that polymyxins cause only minimal 393 disruption to model phospholipid membranes unless LPS is present [15, 20] . 394 15 Whilst the interaction of colistin with LPS in the CM is likely to share similarities with the same process at the 395 OM, there are also likely to be differences owing to the differing concentrations of LPS between the two 396 membranes [21] . In the OM, LPS is a highly abundant component with molecules tightly packed and stabilised 397 with cation bridges. By contrast, LPS is a minority component in the CM, which may affect the rate and degree 398 to which the CM is disrupted by polymyxins. For example, previous work showed a direct correlation between 399 the concentration of LPS in a model membrane and the extent to which the membrane was permeabilised 400 by colistin [20] . 401
In keeping with this, we observed that colistin induced OM damage within minutes of bacterial exposure to 402 the antibiotic, but disruption of the CM took much longer. Part of this delay may be due to the time taken 403 for the polymyxin to traverse the OM, since polymyxins accumulate on the bacterial surface before migrating 404 to the CM [37]. However, when spheroplasts lacking an OM were exposed to colistin, it still took more than 405 2 hours for CM permeabilisation to occur. Therefore, it appears that colistin-mediated disruption of the CM 406 is considerably less efficient than that of the OM. 407
Additional evidence for polymyxin targeting of LPS in the CM came from our studies with E. coli expressing 408 mcr-1, a plasmid-borne colistin resistance determinant that is the most prevalent member of the mcr family 409 of gene homologues and a growing cause for concern. MCR-1 functions by modifying the lipid A domain of 410 LPS with a phosphoethanolamine moiety, preventing colistin binding. However, recent work showed that 411 MCR-1 did not prevent colistin-mediated OM permeabilisation, calling into question how this enzyme confers 412 polymyxin resistance [17] . Phosphoethanolamine modifications of LPS have been shown to occur in the CM 413 before trafficking to the OM, and our data demonstrate that it is the presence of modified LPS in the CM that 414 confers protection from colistin on E. coli expressing mcr-1, since the CM of spheroplasts from MCR-1-415 producing bacteria was not damaged by the polymyxin antibiotic [35] . 416
All mcr homologues are thought to act at the CM, so it is likely that our findings are generalizable to this 417 mechanism of colistin resistance [11] [12] [13] [14] . However, colistin resistance in other species that occurs via 418 chromosomal mutations or the induction of stress responses is more complex, and it remains to be seen 419 whether these diverse mechanisms confer colistin protection through modified LPS in the CM or OM [28-420 30,38]. It is also not yet clear why colistin is able to disrupt the OM but not CM of bacteria expressing mcr-1. 421 However, as discussed above, there are likely to be important differences in antibiotic activity due to the 422 relative abundance of modified LPS in the CM versus OM. 423
In summary, this work contributes to our understanding of the mechanism of action of colistin by 424 demonstrating that LPS in the CM is targeted by the polymyxin and is required for the bactericidal and lytic 425 activities of the antibiotic. In addition, our findings provide insight into how mcr-1 confers colistin resistance, 426 laying the foundations for developing new therapeutic strategies to enhance the efficacy of colistin. 427 428 16
Methods
429
Bacterial strains and growth conditions 430
The bacterial strains used in this study are listed in Supplementary Table 1 . For each experiment, bacteria 431 were grown for 18 h to stationary phase at 37°C with shaking (180 r.p.m.). All strains were grown in Luria 432 broth (LB; Thermo Fisher Scientific, USA), with the exception of P. aeruginosa strain A23, which was cultured 433 in Tryptic Soy Broth (TSB; BD Biosciences, USA), and K. pneumoniae strain KPC, which was grown in Brain 434
Heart Infusion Broth (BHI; VWR International, USA). For routine culture of bacteria on solid media, strains 435 were grown on the relevant media as described above supplemented with 1.5% technical agar (BD 436 Biosciences). Growth media were supplemented with chloramphenicol (25 μg ml -1 ), gentamicin (15 μg ml -1 ), 437 tetracycline (12.5 μg ml -1 ) or 0. into each well of the microtitre plate to a final concentration of 5 x 10 5 c.f.u. ml -1 . The microtitre plates were 451 then incubated statically at 37°C for 18 h in air, after which point the MIC was defined as the lowest antibiotic 452 concentration at which there was no visible growth of bacteria. In some cases, the extent of bacterial growth 453 after 18 h incubation was also determined by obtaining OD595nm measurements using a Bio-Rad iMark 454 microplate absorbance reader (Bio-Rad Laboratories, USA). 455
Production of spheroplasts 456
Spheroplasts of P. aeruginosa and E. coli strains lacking an OM and cell wall were generated as previously 457 described [40] [41] [42] . Briefly, stationary-phase bacteria grown overnight were washed twice by centrifugation 458 (12,300 x g, 3 min) followed by resuspension in MHB, and added at a final inoculum of 10 8 c.f.u. ml -1 to 9 ml 459 MHB, containing for some experiments the LPS biosynthesis inhibitors CHIR090 or cerulenin. Cultures were 460 then incubated at 37°C with shaking (180 r.p.m.) for 2 h. After the incubation, bacteria were washed twice 461 by centrifuging (3,273 x g, 20 min, 4°C) and resuspending first in 10 ml Tris buffer (0.03 M, pH 8.0, Sigma-462 Aldrich), and subsequently in Tris buffer (0.03 M, pH 8.0) containing 20% sucrose. EDTA (250 µl, 10 mg ml -1 ) 463 and lysozyme (1 ml, 10 mg ml -1 , Roche, Switzerland) were added to remove the OM and cell wall respectively, 464 and the cell suspension was incubated for 1 h in a water bath shaker at 30°C. Trypsin (500 µl, 10 mg ml -1 , 465 Sigma-Aldrich) was then added, and the culture again incubated at 30°C in a water bath shaker for 15 min. 466
The resulting spheroplasts produced were harvested by mild centrifugation (2,000 x g, 20 min, 4°C) and 467 resuspended in 1 ml Tris buffer (0.03 M, pH 8.0) containing 20% sucrose. Successful conversion of bacterial 468 whole cells into spheroplasts was confirmed using phase-contrast microscopy, as detailed below. 469
Fluorescent labelling of antibiotics 470
Colistin, polymyxin B and PMBN were all labelled with the fluorophore BoDipy FL SE D2184 (Thermo Fisher 471 Scientific) by incubating 100 μl of the BoDipy NHS ester compound (10 mg ml -1 in dimethyl sulfoxide, DMSO) 472 with 250 μl of the antibiotics (10 mg ml -1 ) and 650 μl sodium bicarbonate (0.2 M, pH 8.5) for 2 h at 37°C. 473
BoDipy molecules that had not bound to the antibiotics were removed by dialysis using a Float-A-Lyser G2 474 dialysis device (Spectrum Laboratories, USA) that had a molecular weight cut-off of 0.5 kDa. Dialysis was 475 carried out at 4°C against sterile distilled water, which was changed four times during the course of the 24 h 476 dialysis period. Time of flight mass spectrometry analysis confirmed successful labelling of the polymyxin 477 compounds with the fluorophore, and the antibiotic activity of BoDipy-labelled colistin and BoDipy-polymyxin 478 B was assessed using MIC and bacterial survival assays, as described in the relevant sections. 479
Microscopic analysis 480
For phase-contrast and fluorescence microscopy, a 5 µl sample of fixed bacterial whole cells or spheroplasts 481 was spotted onto a thin 1.2% agarose gel patch prepared in distilled water on a microscope slide. Bacteria 482 were imaged using an Axio Imager.A2 Zeiss microscope (Carl Zeiss Microscopy GmbH, Germany) at 1000x 483 magnification with an oil immersion objective lens. The ZEN 2012 software was used for image acquisition, 484 whilst analysis of cell length:width ratios was done using the FIJI/ImageJ software by measuring two 485 perpendicular lines drawn through the centre of bacteria. For each experiment, all microscopy images were 486 acquired and processed using identical settings throughout. 487
Determination of LPS levels on cell surface 488
To detect and quantify the amount of LPS present in the OM of whole cells and CM of spheroplasts, a 489 fluorescently-labelled form of PMBN (BoDipy-PMBN) was used as a probe, as described previously [25] . For 490 whole cells, stationary-phase bacterial cultures grown overnight were washed twice by centrifugation 491 (12,300 x g, 3 min) and resuspension in MHB, before being added at a final inoculum of 10 8 c.f.u. ml -1 to 9 ml 492 MHB containing CHIR090 or cerulenin where required. Bacteria were then incubated at 37°C with shaking 493 (180 r.p.m.) for 2 h, after which point cells were washed by centrifuging (3,273 x g, 20 min, 4°C) and 494 18 resuspending in 1 ml Tris buffer (0.03 M, pH 8.0). Washed bacteria were recovered by centrifugation (12,300 495
x g, 3 min) and fixed by resuspending in 1 ml of 4% PFA in phosphate-buffered saline (PBS). Similarly, 496 spheroplasts generated as detailed above were harvested by mild centrifugation (4,000 x g, 5 min), and fixed 497 in the same way as for whole cells. Following fixation for 1 h at room temperature, both whole cells and 498 spheroplasts were washed twice by centrifuging (12,300 x g, 3 min for whole cells; 4,000 x g, 5 min for 499 spheroplasts) and resuspending in 1 ml Tris buffer (0.03 M, pH 8.0) containing 20% sucrose in the case of 500 spheroplasts. Subsequently, BoDipy-PMBN (7 µg ml -1 ) was added, and the fixed bacterial suspensions were 501 incubated with end-over-end rotation at 37°C for 30 min. After the incubation, to remove any BoDipy-PMBN 502 that was not bound to the cell surface, the whole cells and spheroplasts were again washed twice as stated 
Isolation of CHIR090-resistant mutants 546
Cultures of P. aeruginosa grown overnight to stationary-phase were washed twice in MHB as described above 547 and diluted 10-fold to an inoculum of 10 8 c.f.u. ml -1 in MHB, before 100 µl of this inoculum was spread across 548 the surface of an MHA plate. A well measuring 10 mm in diameter was made in the agar plate and filled with 549 130 µl of the LPS biosynthesis inhibitor CHIR090 (8 µg ml -1 ). After static incubation of the agar plate at 37°C 550 for 18 h in air, mutants with spontaneous resistance to CHIR090 were isolated by picking colonies that had 551 grown within the zone of inhibition around the well. These resistant mutants were grown overnight to 552 stationary-phase, and again exposed to CHIR090 in a well as described above to confirm that the strains had 553 a reduced susceptibility to the antibiotic. Bacterial growth, survival and MIC assays were performed as 554 detailed in the relevant sections to characterise the properties of the resistant P. aeruginosa isolates. 555
Determination of membrane lipid release from bacteria 556
Stationary-phase bacteria grown overnight were washed twice in MHB and exposed to the relevant 557 antibiotics in 3 ml MHB at a final inoculum of 10 8 c.f.u. ml -1 as described above. Cultures were incubated for 558 8 h at 37°C with shaking (180 r.p.m.), and every 2 h the supernatants were recovered by centrifugation 559 (12,300 x g, 3 min). Recovered supernatants (200 µl) were mixed with 5 μl of FM-4-64 styryl dye (Thermo 560 20 Fisher Scientific) at a final concentration of 5 μg ml -1 in the wells of a black-walled microtitre plate. 561
Fluorescence was measured using a Tecan Infinite 200 Pro multiwell plate reader (excitation at 565 nm, 562 emission at 600 nm) to quantify the phospholipid released into the supernatant by bacteria. 563
Determination of LPS release from bacteria 564
Culture supernatants from bacteria exposed to the relevant antibiotics were recovered as detailed above, 565 and the chromogenic Limulus Amebocyte Lysate (LAL) assay (all reagents from Thermo Fisher Scientific) was 566 used to quantify LPS released from bacteria into the culture supernatant as described previously [43] . 567
Samples of cell-free culture supernatant (50 μl) were equilibrated to 37°C and loaded into the wells of a 568 microtitre plate at the same temperature. Limulus amebocyte lysate reagent (50 μl) was added to each well, 569 and the mixture incubated at 37°C for 10 min. Chromogenic substrate solution (100 μl, 2 mM) was 570 subsequently added to each well and the microtitre plate was incubated for a further 6 min at 37°C. The 571 enzymatic reaction was stopped by adding 50 μl of 25% acetic acid to each well, and the presence of LPS was 572 determined by measuring absorbance at 405 nm in a Tecan Infinite 200 Pro multiwell plate reader. A standard 573 curve was generated using an E. coli endotoxin standard stock solution, which enabled the conversion of 574
A405nm values into concentrations of LPS in the supernatant. 575
Determination of colistin activity 576
As described above, spent culture supernatants from bacteria exposed to the relevant antibiotics were 577 recovered and the activity of colistin in the supernatant was determined using an established zone of 578 inhibition assay [44] . Stationary-phase P. aeruginosa was diluted in MHB to a concentration of 10 6 c.f.u. ml -1 579 before 60 μl of this bacterial culture was spread across the surface of an MHA plate and allowed to air-dry. 580
Wells measuring 10 mm in diameter were made in the agar plate and filled with 130 μl of the culture 581 supernatant recovered from colistin-treated bacterial populations. Agar plates were incubated in air statically 582 at 37°C for 18 h and the zone of growth inhibition around each well was measured at four perpendicular 583 points. A standard plot was generated showing a linear relationship between the size of the zone of inhibition 584 and colistin concentration, which enabled inhibitory zone size to be converted to percentage colistin activity. 585
Scanning electron microscopy (SEM) imaging 586
Stationary-phase bacterial cells grown overnight were washed and inoculated into 3 ml MHB containing the 587 relevant antibiotics as described above. After 2 h incubation (37°C, 180 r.p.m.), 25 μl of the cultures was 588 spotted onto a silicon chip (University Wafer, USA) and allowed to air-dry. The sample was fixed using 589 glutaraldehyde (2.5% in 0.01 M PBS) for 30 min at room temperature, before the chip was washed three 590 times in PBS (0.01 M). The sample was dehydrated using increasing concentrations of ethanol (10%, 30%, 591 50%, 70%, 90% and 100%) for 5 min each time, before a coating of 15 nm chromium (Quorum Technologies, 592 21 UK) was applied. Representative images of bacterial cells were obtained using a LEO Gemini 1525 field 593 emission gun scanning electron microscope (FEG SEM; Carl Zeiss Microscopy GmbH). 594
Cytoplasmic membrane disruption assay 595
To measure CM disruption of whole cells, as described above bacteria grown to stationary-phase overnight 596 were washed and inoculated into 3 ml MHB containing the relevant antibiotics. Cultures were incubated at 597
